Manufacturing
Research And Development
Technology

Cerus

$5.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (1.57%) Today
-$0.10 (-1.93%) After Hours

Why Robinhood?

You can buy or sell Cerus and other stocks, options, ETFs, and crypto commission-free!

About

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The company produces blood system for platelets and plasma. Read More It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Employees
240
Headquarters
Concord, California
Founded
1991
Market Cap
704.25M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
862.62K
High Today
$5.25
Low Today
$5.00
Open Price
$5.12
Volume
583.86K
52 Week High
$8.05
52 Week Low
$4.71

Collections

Manufacturing
Research And Development
Technology
Health
Medical

News

Yahoo FinanceMay 7

Here’s What Hedge Funds Think About Cerus Corporation (CERS)

The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed heavily on the minds of investors.

148

Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.